Recent Client Publishing Successes

May 29th 2019

Coraggio is Our 4th Client to Land a Forbes Contributor Role

Trever Cartwright becomes the latest thought leader we've helped to secure a coveted spot in's highly read Leadership section.

February 5th 2019

Founders, This Fear is Hindering Your Company’s Success

Our client Matt Brubaker, chief executive officer at FMG Leading, discusses in his article on how fear can prevent a company from achieving success. He uses his own experience at FMG Leading as a prime example.

January 8th 2019

What Successful Public-Private Partnerships Do

In this article in Harvard Business Review, Elyse Maltin, an associate consultant at JMW Consultants Inc., explains how large public-private infrastructure projects that involve multiple organizations need to be managed. If the companies cannot work together effectively, costs can go way over budget and projects are seldom completed on time.

December 20th 2018

How To Make Americans Healthier: Rank Food Companies

In December 2018, published an article by our client Hank Cardello of the Hudson Institute.

December 4th 2018

To Retain Employees, Focus on Inclusion – Not Just Diversity

In this HBR article, our client Karen Brown discusses how to retain more employees by getting beneath “identity cover” – the parts of themselves that employees hide, such as religion and sexual orientation, when they differ from the majority of their colleagues.

November 30th 2018

Food Companies Must Change Before Doomsday Labeling Kills Them

In this article on, our client, Hank Cardello, discusses the need for food companies to improve their food and drink formulations. Governments outside of the U.S. are promoting black “stop signs” and “traffic light” labels for ingredients on packaging.

October 22nd 2018

3 Ways to Help Public Health Activists Think Like Marketers

Bloom Group client, Hank Cardello, argues that good health and nutrition are out of reach for some of the American population, and over one third of our population is obese.

September 17th 2018

5 Ways Big Food Companies Can Make America (And Themselves) Healthier

In September 2018, Bloom Group client Hank Cardello published an article on on the consumer shift from mass-produced packaged brands to local, healthier food. As top food brands’ market shares decline, food companies need to do more to sustain their successes.

August 30th 2018

Restaurants Have Gotten A Hall Pass on Obesity, And It Must End

In this article, Hank Cardello, a senior fellow of Hudson Institute, argues that the restaurant industry must be held accountable to reduce portion sizes, cut calories, and publicly promote healthier options.

July 17th 2018

4 Signs an Executive Isn’t Ready for Coaching

For the fourth time in two years, the Harvard Business Review has published an article that Bloom Group helped FMG Leading develop.

April 4th 2018

In Cyber-Defense, Good Enough is Far Better Than Perfect

Bloom Group assisted Col. Jeffery A. Collins, director of Air Force CyberWorx, develop an article on better ways to defend organizations against cyber-attacks.

January 15th 2018

Turning Doctors into Healthcare Leaders

This is the third Harvard Business Review article that Bloom Group has helped our client FMG Leading publish in the last two years. The article, which HBR ran on Dec. 15, 2017, is by Jennifer Perry, Dr. Foster Mobley and Dr.

January 15th 2018

Why Employee Retention Falls Short

In 2017, Bloom Group worked with a consulting and training company, Career Systems International (CSI), to capture its expertise on employee retention. The first step was creating what we refer to as a “keystone” document, which explained CSI’s point of view on the issue.

December 12th 2017

Let's Talk About Sex

Dede Henley is the founder and CEO of Henley Leadership Group. One of the reasons she founded Henley Leadership is because as a younger woman she experienced sexual harassment on the job and didn't want a career that left her vulnerable to the predations of male bosses. Recently, Henley became a Forbes contributor, writing about how leaders can create healthy, productive organizational cultures in which what happened to her won't (and can't) happen to others.

December 11th 2017

Harnessing Your Boardroom Fears

This is FMG Leading’s second Harvard Business Review article. Published in October 2017, the authors CEO Matt Brubaker and Chairman Foster Mobley explain four fears they've seen hold many executives back from reaching their potential: of being wrong, of not being good enough, of missing out, and of being taken advantage of. They explain how executives can harness these fears and become far more effective leaders.

May 30th 2017

AI's Value is More Than Replacing People

Satya Ramaswamy is senior vice president of digital enterprise services at Tata Consultancy Services, the $16 billion global IT services and consulting firm. In April 2017, he published his third article in four years, "How Companies Are Already Using AI," in the Harvard Business Review, based on research that TCS conducted on how big companies around the world are using artificial intelligence. (Bloom Group has helped Satya and TCS place all three articles.)

May 30th 2017

Why Soda Taxes Won't Solve Obesity

In May 2017,'s Leadership section published "How A Billion Dollars Is Being Wasted In The War On Sugar," an article by our client Hank Cardello of the Hudson Institute. It was Cardello's 21st article since 2012. The Bloom Group has helped him with all of them.

September 16th 2016

Avoiding an Expensive Mistake

According to Bain & Co. half the private equity firms it studied had replaced the CEOs of their portfolio companies, and more than half (60%) hadn’t planned to. That means those PE firms had made a big, fat, expensive mistake. Bloom Group client FMG Leading, a human capital advisory firm, has developed a proprietary process for assessing the potential of CEOs for PE firms, and in Sept.

August 29th 2016

Keys to Mitigating Risk in Adaptive Trials

Phase III trials, the last before a drug is submitted to a regulatory agency for approval, cost about $20 million. The fact that about 50% of them fail is a big problem. Sy Pretorius, Chief Scientific Officer of PAREXEL, a leading global pharmaceutical consulting firm, believes this high rate of failure is caused by traditionally rigid trial designs. He argues that designs that enable trials to change as new data is collected can reduce failures. We helped Pretorius publish his article, "Three Keys to Mitigating Risk in Adapative Trials," in Life Science Leader.

July 24th 2016

New Drug Submission Rules: A How-To

The FDA has mandated that by May 2017 all new drug applications must be submitted electronically in a format called eCTD. For drug developers to comply, they will need new tools, workflows, and publishing strategies.

July 15th 2016

Cisco’s Innovation Secrets

Gartner predicts that by 2020 there will be 21 billion things in the Internet of Things. Figuring out how all those things will share and process data, how they will be made secure, and how platforms and architectures can be built that will allow them to work together requires rapid, industrialized innovation. Bloom Group helped Cisco Systems Corporate Director Stephan Monterde share some of his company’s strategies for accelerating innovation in “How We Think About Innovation at Cisco” for

June 7th 2016

How to De-Risk Complex Molecule Formulation

If formulation problems surface late in the process of turning active pharmaceutical ingredients (APIs) into beneficial drugs, developers may have to change their API production processes, or even redo Phase I and Phase II trials.

May 24th 2016

The Perils of Underpricing New Products

Simon-Kucher & Partners, a $200 million+ management consulting firm specializing in marketing, sales and pricing strategies, asked us in 2015 to turn its product innovation expertise into a book. After finding an agent and helping the authors, Madhavan Ramanujam (an SKP partner) and Georg Tacke (co-CEO), capture their ideas in a manuscript, Bloom Group worked with SKP in 2016 to market the book (Monetizing Innovation: How Smart Companies Design the Product Around the Price) through two articles. This, the second article (“Your New Hit Product Might Be Underpriced”), ran in the publication’s May 24, 2016 online edition.

May 9th 2016

Innovation Lessons from Porsche and Fiat Chrysler

The first of two Harvard Business Review articles Bloom Group helped Simon-Kucher & Partners' Madhavan Ramanujam and Georg Tacke prepare to publicize their book Monetizing Innovation. “In Product Development, Let Your Customers Define Perfection” compares the launch of Porsche's Cayenne SUV in the early 2000s and Fiat Chrysler’s Dodge Dart about 10 years later. The Cayenne became a huge hit; the Dart flopped. The article, which ran in the May 9, 2016 online edition of HBR, explains why. 


May 2nd 2016

Monetizing Innovation

Simon Kutcher & Partners (SKP) is a global management consulting firm.

April 30th 2016

Speeding Drugs to Market

The FDA is creating new pathways to shorten the time it takes for new medicines to receive regulatory approval. However, meeting FDA requirements for these pathways can be a tricky business. PAREXEL is a leading international drug consulting firm, and Bloom Group helped PAREXEL Vice President Barry Farrimond, Network for Excellence in Health Innovation President Jonathan Fleming, and PAREXEL expert Mark Mathieu place their article “FDA’s Accelerated Pathways Are the New Normal” in DIA, the publication of the Drug Information Association.

April 13th 2016

The National Football League and Its Attackers

Hudson Institute Senior Fellow Hank Cardello weighs in on the latest round between the NFL and the growing number of activists who are attacking its stand on concussions. In his latest post, Cardello suggests that the NFL should recognize those who are railing against it as an important market segment, not as a parariah.

January 2nd 2016

Waste-Not Want-Not Formulation and Process Design

Developers must make important decisions about product formulation and process design to move a drug from preclinical through Phase II trials as quickly as possible. Over-engineering a Phase I or Phase II drug that ultimately fails in the clinic wastes resources. But neglecting sound science during early stages can result in a promising product that may not have a scalable or commercially manufacturing process.

November 4th 2015

Asian Supply Chain Mysteries

An Oregon woman opens a box of Halloween decorations she bought at her local K-Mart and out falls a note pleading for help, written by a man in a Chinese prison camp. How does this happen? According to FTI Consulting Forensic & Litigation Consulting Senior Director Greg Hallahan, Western companies that outsource manufacturing to Asia do a pretty good job vetting their suppliers, but not such a good job checking to see if their suppliers are subcontracting the work out. We helped Hallahan repurpose his article in FTI Journal, for Thomson Reuters News and for Supply & Demand Chain Executive.

October 8th 2015

Innovation Goes Better At Coke

Bloom Group has assisted Brad Power, a Partner at advisory, educational, and research firm FCB Partners, publish many articles in many journals, including Here, in "How Coca-Cola Uses Entrepreneurs (and Keurig) to Jump-Start Innovation," Power reports on the company's arm's-length-yet-nurturing approach to start-ups, which enables it to incorporate innovation into its business processes without stifling it with process bureaucracy.

October 5th 2015

Solving for Solubility

Solubility is a key issue when formulating drugs for manufacture, and the proportion of new drugs that are hard to dissolve has been increasing. There are lots of formulation technologies available to drug manufacturers to address solubility, but it’s not always easy to know which one is best for a new drug.

October 1st 2015

Fighting Pharma Demand Forecast Fails

Given the long road drugs must travel to get to market, developers have to predict demand, and line up production capacity, years before a new product launches. If they guess too low, they won’t have enough to meet demand (causing reputational damage and the loss of potential revenue). If they guess too high, they’re stuck with product they can’t sell.

September 29th 2015

Taking Coke and Its Attackers to Task

Coca-Cola Co. has made lots of headlines in the summer and fall of 2015, not all of them good. The company was criticized for not disclosing its investments in health organizations and health research initiatives. In his latest post for (“Shame Is a Losing Strategy for Both Coke And Its Attackers”), our client Hank Cardello (head of the Obesity Solutions initiative at the Washington, D.C., think-tank the Hudson Institute) discusses the criticism lobbied against Coke, and why the beverage giant’s new transparency about who it funds is good but not good enough. You can read his article (published in September) here

July 24th 2015

Fighting Bribery and Fraud in Emerging Markets

Matías Mora Simoes is a Senior Managing Director in the FTI Consulting Forensic and Litigation Consulting practice and is the head of the FTI Consulting Panama and FTI Consulting Mexico offices. We helped him place his article, “What Companies Do Right (and Wrong) Fighting Bribery and Fraud in Emerging Markets,” based on FTI Consulting research, in Corporate Compliance Insights. You can read the article, here.

July 24th 2015

Avoiding Risk in Emerging Markets: A Study

The Bloom Group helped FTI Consulting, an international business advisory firm, conduct a quantitative and qualitative survey of global business leaders to discover how leading companies successfully mitigated the many risks of doing business in emerging markets, and what laggard companies were doing wrong. We then helped FTI Consulting’s senior leaders publish the survey’s findings, and many articles derived from them, in several executive journals, including the online edition of The Harvard Business Review, Risk Management Monitor, Corporate Compliance Insights, and

May 22nd 2015

Mighty Midsized Companies

The Bloom Group helps experts create, publish, and promote books, increasing sales and widening reach.

April 13th 2015

Big Food's Collaboration Lessons for Congress

Our client Hank Cardello of the Hudson Institute writes in his latest guest commentator post for about what Washington could learn from the food industry on how to work with anti-industry activitists. Through a number of initiatives, the food industry and many of its critics have found common ground in the fight against obesity and for healthier food. You can read Hank's article here

April 11th 2015

The How and Why of Telemedicine

The use of telemedicine is on the rise; it's benefits are obvious to patients and providers, but there remain social and regulatory hurdles to surmount. We helped  FTI Consulting Senior Managing Director Wayne Gibson, and FTI Consulting Health Solutions Managing Director Jeffrey Bessette suggest ways to leap those hurdles in "The How and Why of Telemedicine," published in Health Management Technology.

January 13th 2015

Oil and Gas Industry Gets Social Media Wrong

Steve Everley is a Senior Director at FTI Consulting, advising clients in a broad range of industries, including coal, refining and LNG exports. Everley published an article in FTI Journal, “Drilling for a Social Media Strategy,” here, about how social media, which can target small groups and communicate with them in an intimate manner, is a better communication channel for the oil and gas industry than the national marketing efforts it has heretofore focused upon. The industry has left social media to its activist opponents. It can do so no longer.

In December, we helped Everley publish a version of his FTI Journal article in industry publication OGI, here.

December 24th 2014

Taking Business School Research Out of the Ivory Tower

Why studies need to be much more relevant to corporations, and how to do so.